[Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation].
D000208:Acute Disease; D000276:Adjuvants, Immunologic; D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000188:drug therapy; D001835:Body Weight; D004487:Edema / Q000188:drug therapy; D005439:Flufenamic Acid / Q000494:pharmacology; D005753:Gastric Mucosa / Q000187:drug effects; D006099:Granuloma / Q000188:drug therapy; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D009929:Organ Size; D010653:Phenylbutazone / Q000494:pharmacology; D011241:Prednisone / Q000494:pharmacology; D051381:Rats; D014945:Wound Healing / Q000187:drug effects; D062367:ortho-Aminobenzoates / Q000494:pharmacology* / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D010653:Phenylbutazone; D011241:Prednisone; D007213:Indomethacin